Your browser doesn't support javascript.
loading
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia.
Boyiadzis, Michael; Desai, Pinkal; Daskalakis, Nikki; Donnellan, William; Ferrante, Lucille; Goldberg, Jenna D; Grunwald, Michael R; Guttke, Christina; Li, Xiang; Perez-Simon, Jose Antonio; Salamero, Olga; Tucker, Trevor; Xu, Xiaoying; Yang, Jay; Pemmaraju, Naveen; Alonso-Dominguez, Juan Manuel.
Afiliación
  • Boyiadzis M; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Desai P; Weill Cornell Medicine, New York-Presbyterian, New York, New York, USA.
  • Daskalakis N; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Donnellan W; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA.
  • Ferrante L; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Goldberg JD; Janssen Research & Development, Somerville, New Jersey, USA.
  • Grunwald MR; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Guttke C; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Li X; Janssen Research & Development, Somerville, New Jersey, USA.
  • Perez-Simon JA; Instituto de Biomedicina de Sevilla (IBIS/CISC), Universitario Virgen del Rocio, Universidad de Sevilla, Sevilla, Spain.
  • Salamero O; Vall d'Hebron University Hospital, VHIO, Barcelona, Spain.
  • Tucker T; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Xu X; Janssen Research & Development, Somerville, New Jersey, USA.
  • Yang J; Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Pemmaraju N; MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Alonso-Dominguez JM; Hematology Department, Early Phase Clinical Trials Unit START Madrid-FJD, Fundacion Jiménez Díaz University Hospital, Madrid, Spain.
Clin Transl Sci ; 16(3): 429-435, 2023 03.
Article en En | MEDLINE | ID: mdl-36564917

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antineoplásicos Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Antineoplásicos Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos